CAM
PRAX icon

Congress Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Congress Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,839
Closed -$8M – 421
2026
Q1 		$8M Sell
24,839
-6,407
-21% -$1.98M 0.06% 221
2025
Q4 		$9.21M Buy
31,246
+807
+3% +$150K 0.06% 199
2025
Q3 		$1.61M Buy
+30,439
New +$1.48M 0.01% 296

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Congress Asset Management's PRAX Position: Q2 2026 in Review

Congress Asset Management sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 24,839 shares — an estimated $8M sold.

Congress Asset Management first reported a position in PRAX in Q3 2025 and held it in 3 quarters. The position peaked at $9.21M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Congress Asset Management reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Congress Asset Management sold 24,839 Praxis Precision Medicines shares in Q2 2026, an estimated $8M.
  • Congress Asset Management first reported a position in Praxis Precision Medicines in Q3 2025 and held it in 3 quarters.
  • Congress Asset Management's Praxis Precision Medicines position peaked at $9.21M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.